GSK 257049 Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 257049 Vaccine, covering 2014-03-27 to 2014-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine [Phase 2]